"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

May 30, 2025

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Trimetazidine

an anti-ischemic medication.

Trial Locations (1)

Ain Shams University Hospital, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06656442 - "The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients" | Biotech Hunter | Biotech Hunter